Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics

Journal of Molecular Medicine

Volumn 85, Issue 7, 2007, Pages 733-743

  Ostrowski, Jerzy ^a   Mikula, Michal ^a   Karczmarski, Jakub ^a   Rubel, Tymon ^b   Wyrwicz, Lucjan S ^a   Bragoszewski, Piotr ^a   Gaj, Pawel ^a   Dadlez, Michal ^c   Butruk, Eugeniusz ^a   Regula, Jaroslaw ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^c INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

Barrett's esophagus; Defense mechanisms; Gene expression; Integrative genomics; Microarrays; Proteomics

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; BASEMENT MEMBRANE; BIOENERGY; CELL PROTECTION; CONTROLLED STUDY; ESOPHAGUS MUCOSA; EXTRACELLULAR MATRIX; FUNCTIONAL GENOMICS; GEL ELECTROPHORESIS; GENE OVEREXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; PHOSPHOINOSITIDE METABOLISM; PROSTAGLANDIN SYNTHESIS; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REFLUX ESOPHAGITIS; SQUAMOUS CELL METAPLASIA; TIGHT JUNCTION; TRANSCRIPTION REGULATION;

ADAPTATION, PHYSIOLOGICAL; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MALE; METAPLASIA; MUCOUS MEMBRANE; PRECANCEROUS CONDITIONS; PROTEOMICS; TRANSCRIPTION, GENETIC;

EID: 34447328450     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0176-3     Document Type: Article

References (58)

1. Sampliner RE (2002) Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 97:1888-1895
2. Orlando RC (2006) Mucosal defense in Barrett's esophagus In: Sharma P, Sampliner RE (eds) Barrett's esophagus and esophageal adenocarcinoma. Blackwell, Malden, MA, pp 60-72
3. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA (1990) Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 99:918-922
4. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG (1989) Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 96:1249-1256
5. McArdle JE, Lewin KJ, Randall G, Weinstein W (1992) Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Human Pathol 23:479-482
6. Rosenberg JC, Budev H, Edwards RC, Singal S, Steiger Z, Sundareson AS (1985) Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system. Cancer 55:1353-1360
7. Schmidt HG, Riddell RH, Walther B, Skinner DB, Riemann JF (1985) Dysplasia in Barrett's esophagus. J Cancer Res Clin Oncol 110:145-152
8. Ostrowski J, Rubel T, Wyrwicz LS, Mikula M, Bielasik A, Butruk E, Regula J (2006) Three clinical variants of gastroesophageal reflux disease form two distinct gene expression signatures. J Mol Med 84(10):872-882
9. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou JF, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H, Yamabe H (2000) The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47:251-255
10. Mikula M, Dzwonek A, Karczmarski J, Rubel T, Dadlez M, Wyrwicz LS, Bomsztyk K, Ostrowski J (2006) Landscape of the hnRNP K protein-protein interactome. Proteomics 6:2395-2406
11. Mikula M, Karczmarski J, Dzwonek A, Rubel T, Hennig E, Dadlez M, Bujnicki JM, Bomsztyk K, Ostrowski J (2006) Casein kinases phosphorylate multiple residues spanning the entire hnRNP K length. Biochim Biophys Acta 1764:299-306
12. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C, Richter J, Rubin GM, Blake JA, Bult C, Dolan M, Drabkin H, Eppig JT, Hill DP, Ni L, Ringwald M, Balakrishnan R, Cherry JM, Christie KR, Costanzo MC, Dwight SS, Engel S, Fisk DG, Hirschman JE, Hong EL, Nash RS, Sethuraman A, Theesfeld CL, Botstein D, Dolinski K, Feierbach B, Berardini T, Mundodi S, Rhee SY, Apweiler R, Barrell D, Camon E, Dimmer E, Lee V, Chisholm R, Gaudet P, Kibbe W, Kishore R, Schwarz EM, Sternberg P, Gwinn M, Hannick L, Wortman J, Berriman M, Wood V, de la Cruz N, Tonellato P, Jaiswal P, Seigfried T, White R (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32:D258-D261
13. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34:D354-D357
14. Beisvag V, Junge FK, Bergum H, Jolsum L, Lydersen S, Gunther CC, Ramampiaro H, Langaas M, Sandvik AK, Laegreid A (2006) GeneTools-application for functional annotation and statistical hypothesis testing. BMC Bioinformatics 7:470
15. Peano C, Severgnini M, Cifola I, De Bellis G, Battaglia C (2006) Transcriptome amplification methods in gene expression profiling. Expert Rev Mol Diagn 6:465-480
16. Flucke U, Steinborn E, Dries V, Monig SP, Schneider PM, Thiele J, Holscher AH, Dienes HP, Baldus SE (2003) Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach. Histopathology 43:127-134
17. Ormsby AH, Goldblum JR, Rice TW, Richter JE, Falk GW, Vaezi MF, Gramlich TL (1999) Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Human Pathol 30:288-294
18. Bi LC, Kaunitz JD (2003) Gastroduodenal mucosal defense: an integrated protective response. Curr Opin Gastroenterol 19:526-532
19. Shim JO, Shin CY, Lee TS, Yang SJ, An JY, Song HJ, Kim TH, Huh IH, Sohn UD (2002) Signal transduction mechanism via adenosine A1 receptor in the cat esophageal smooth muscle cells. Cell Signal 14:365-372
20. Jaiswal K, Tello V, Lopez-Guzman C, Nwariaku F, Anthony T, Sarosi GA Jr (2004) Bile salt exposure causes phosphatidyl-inositol-3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line. Surgery 136:160-168
21. Kashiwagi M, Ohba M, Chida K, Kuroki T (2002) Protein kinase C eta (PKC eta): its involvement in keratinocyte differentiation. J Biochem (Tokyo) 132:853-857
22. Nishio H, Hayashi Y, Terashima S, Takeuchi K (2006) Role of endogenous nitric oxide in mucosal defense of inflamed rat stomach following iodoacetamide treatment. Life Sci 79:1523-1530
23. Wallace JL (1996) Cooperative modulation of gastrointestinal mucosal defence by prostaglandins and nitric oxide. Clin Invest Med 19:346-351
24. Das AM (2003) Regulation of the mitochondrial ATP-synthase in health and disease. Mol Genet Metab 79:71-82
25. Mikula M, Dzwonek A, Hennig EE, Ostrowski J (2005) Increased mitochondrial gene expression during L6 cell myogenesis is accelerated by insulin. Int J Biochem Cell Biol 37:1815-1828
26. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR (2002) GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31:19-20
27. Kaunitz JD, Akiba Y (2004) Gastroduodenal mucosal defense: role of endogenous mediators. Curr Opin Gastroenterol 20:526-532
28. Lichtenberger LM (1999) Gastroduodenal mucosal defense. Curr Opin Gastroenterol 15:463
29. Levine DS, Rubin CE, Reid BJ, Haggitt RC (1989) Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. Lab Invest 60:418-432
30. Latchford A, Eksteen B, Jankowski J (2001) The continuing tale of cytokeratins in Barrett's mucosa: as you like it. Gut 49:746-747
31. Shedden K, Chen W, Kuick R, Ghosh D, Macdonald J, Cho KR, Giordano TJ, Gruber SB, Fearon ER, Taylor JM, Hanash S (2005) Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling data. BMC Bioinformatics 6:26
32. Playford RJ, Ghosh S (2005) Cytokines and growth factor modulators in intestinal inflammation and repair. J Pathol 205:417-425
33. Ota H, Hayama M, Momose M, El-Zimaity HM, Matsuda K, Sano K, Maruta F, Okumura N, Katsuyama T (2006) Co-localization of TFF2 with gland mucous cell mucin in gastric mucous cells and in extracellular mucous gel adherent to normal and damaged gastric mucosa. Histochem Cell Biol 126(5):617-625
34. Thim L, Madsen F, Poulsen SS (2002) Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest 32:519-527
35. Basson MD (2003) Invited research review: Cell-matrix interactions in the gut epithelium. Surgery 133:263-267
36. Asaoka D, Miwa H, Hirai S, Ohkawa A, Kurosawa A, Kawabe M, Hojo M, Nagahara A, Minoo T, Ohkura R, Ohkusa T, Sato N (2005) Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis. J Gastroenterol 40:781-790
37. Rahner C, Mitic LL, Anderson JM (2001) Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 120:411-422
38. Martin GR, Wallace JL (2006) Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp Biol Medicine (Maywood) 231:130-137
39. Nusrat A, Turner JR, Madara JL (2000) Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 279:G851-G857
40. Wallace JL, Devchand PR (2005) Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense. Br J Pharmacol 145:275-282
41. Yamato M, Nagahama K, Kotani T, Kato S, Takeuchi K (2005) Biphasic effect of prostaglandin E2 in a rat model of esophagitis mediated by EP1 receptors: relation to pepsin secretion. Digestion 72:109-118
42. Ishikawa T, Morris PL (2006) Interleukin-1β signals through a cJun-N-terminal kinase (JNK)-dependent inducible nitric oxide synthase and nitric oxide production pathway in Sertoli epithelial cells. Endocrinology 147(11):5424-5430
43. Li H, Wallerath T, Forstermann U (2002) Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 7:132-147
44. Siddiqui AS, Delaney AD, Schnerch A, Griffith OL, Jones SJ, Marra MA (2006) Sequence biases in large scale gene expression profiling data. Nucleic Acids Res 34:e83
45. Ostrowski J, Wocial T, Skurzak H, Bartnik W (2003) Do altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors? Br J Cancer 88:1143-1151
46. Huang Z, Tunnacliffe A (2004) Response of human cells to desiccation: comparison with hyperosmotic stress response. J Physiol 558:181-191
47. Souza RF, Shewmake K, Pearson S, Sarosi GA Jr, Feagins LA, Ramirez RD, Terada LS, Spechler SJ (2004) Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 287:G743-G748
48. Toivola DM, Zhou Q, English LS, Omary MB (2002) Type II keratins are phosphorylated on a unique motif during stress and mitosis in tissues and cultured cells. Mol Biol Cell 13:1857-1870
49. Petrof EO, Ciancio MJ, Chang EB (2004) Role and regulation of intestinal epithelial heat shock proteins in health and disease. Chinese Journal of Digestive Diseases 5:45-50
50. Guillem PG (2005) How to make a Barrett esophagus: pathophysiology of columnar metaplasia of the esophagus. Dig Dis Sci 50:415-424
51. Gomes LI, Esteves GH, Carvalho AF, Cristo EB, Hirata R Jr, Martins WK, Marques SM, Camargo LP, Brentani H, Pelosof A, Zitron C, Sallum RA, Montagnini A, Soares FA, Neves EJ, Reis LF (2005) Expression profile of malignant and nonmalignant lesions of esophagus and stomach: differential activity of functional modules related to inflammation and lipid metabolism. Cancer Res 65:7127-7136
52. Wang S, Zhan M, Yin J, Abraham JM, Mori Y, Sato F, Xu Y, Olaru A, Berki AT, Li H, Schulmann K, Kan T, Hamilton JP, Paun B, Yu MM, Jin Z, Cheng Y, Ito T, Mantzur C, Greenwald BD, Meltzer SJ (2006) Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. Oncogene 25:3346-3356
53. Barrett MT, Yeung KY, Ruzzo WL, Hsu L, Blount PL, Sullivan R, Zarbl H, Delrow J, Rabinovitch PS, Reid BJ (2002) Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae. Neoplasia 4:121-128
54. El-Serag HB, Nurgalieva Z, Souza RF, Shaw C, Darlington G (2006) Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot study. Gastrointest Endosc 64:17-26
55. van Baal JW, Milano F, Rygiel AM, Bergman JJ, Rosmolen WD, van Deventer SJ, Wang KK, Peppelenbosch MP, Krishnadath KK (2005) A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia. Gastroenterology 129:1274-1281
56. Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422:198-207
57. Godovac-Zimmermann J, Kleiner O, Brown LR, Drukier AK (2005) Perspectives in spicing up proteomics with splicing. Proteomics 5:699-709
58. Greenbaum D, Colangelo C, Williams K, Gerstein M (2003) Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biology 4:117